Encyclopedia of Nanotechnology

Living Edition
| Editors: Bharat Bhushan

Multistage Vectors

  • Rita E. Serda
  • Mauro Ferrari
Living reference work entry
DOI: https://doi.org/10.1007/978-94-007-6178-0_78-2



Multistage vectors are multiparticle, multifunctional vectors strategically envisioned to overcome abundant obstacles encountered by drug delivery vectors as they journey from the site of administration to the target site. These vectors are comprised of layers of particles, with secondary nanoparticles and active agents nested into first-stage porous silicon microparticles. The ability to achieve sequential targeting through particle optimization enhances the probability of reaching the appropriate cellular or subcellular target within a lesion with the appropriate drug. Multistage vectors are a subset of Logic-Embedded Vectors (LEVs) [1]. By definition, LEVs are vectors with the ability to perform a time sequence of functions through the use of multiple nano-based components that synergistically provide distinct functionalities.

Porous Silicon Particles as...


Porous Silicon Iron Oxide Nanoparticles Silicon Particle Endosomal Escape Orthosilicic Acid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.


  1. 1.
    Ferrari, M.: Frontiers in cancer nanomedicine: transport oncophysics and logic-embedded vectors. Trends Biotechnol. 28(4), 181–188 (2010)CrossRefGoogle Scholar
  2. 2.
    Chiappini, C., Tasciotti, E., Fakhoury, J.R., Fine, D., Pullan, L., Wang, Y.C., Fu, L., Liu, X., Ferrari, M.: Tailored porous silicon microparticles: fabrication and properties. Chemphyschem 11(5), 1029–1035 (2010)CrossRefGoogle Scholar
  3. 3.
    Tasciotti, E., Liu, X., Bhavane, R., Plant, K., Leonard, A.D., Price, B.K., Cheng, M.M., Decuzzi, P., Tour, J.M., Robertson, F., Ferrari, M.: Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. Nat. Nanotechnol. 3(3), 151–157 (2008)CrossRefGoogle Scholar
  4. 4.
    Ferrari, M.: Nanovector therapeutics. Curr. Opin. Chem. Biol. 9(4), 343–346 (2005)CrossRefGoogle Scholar
  5. 5.
    Serda, R.E., Godin, B., Blanco, E., Chiappini, C., Ferrari, M.: Multi-stage delivery nano-particle systems for therapeutic applications. Biochim. Biophys. Acta 1810, 317–329 (2010)CrossRefGoogle Scholar
  6. 6.
    Decuzzi, P., Ferrari, M.: Design maps for nanoparticles targeting the diseased microvasculature. Biomaterials 29(3), 377–384 (2008)CrossRefGoogle Scholar
  7. 7.
    Decuzzi, P., Ferrari, M.: Modulating cellular adhesion through nanotopography. Biomaterials 31(1), 173–179 (2010)CrossRefGoogle Scholar
  8. 8.
    Lee, S.Y., Ferrari, M., Decuzzi, P.: Shaping nano-/micro-particles for enhanced vascular interaction in laminar flows. Nanotechnology 20(49), 495101 (2009)CrossRefGoogle Scholar
  9. 9.
    Serda, R.E., Gu, J., Bhavane, R.C., Liu, X., Chiappini, C., Decuzzi, P., Ferrari, M.: The association of silicon microparticles with endothelial cells in drug delivery to the vasculature. Biomaterials 30(13), 2440–2448 (2009)CrossRefGoogle Scholar
  10. 10.
    Serda, R., Robertson, F., Ferrari, M.: Overcoming nature’s fastball – bio-barriers in cancer nanotechnology (not peer reviewed). Nano. Mag. Small Sci. 5, 10–13 (2008)Google Scholar
  11. 11.
    Ferrati, S., Mack, A., Chiappini, C., Liu, X., Bean, A.J., Ferrari, M., Serda, R.E.: Intracellular trafficking of silicon particles and logic-embedded vectors. Nanoscale 2(8), 1512–1520 (2010)CrossRefGoogle Scholar
  12. 12.
    Mann, A.P., Somasunderam, A., Nieves-Alicea, R., Li, X., Hu, A., Sood, A.K., Ferrari, M., Gorenstein, D.G., Tanaka, T.: Identification of thioaptamer ligand against E-selectin: potential application for inflamed vasculature targeting. PLoS One 5(9), e13050 (2010)CrossRefGoogle Scholar
  13. 13.
    Hashizume, H., Baluk, P., Morikawa, S., McLean, J.W., Thurston, G., Roberge, S., Jain, R.K., McDonald, D.M.: Openings between defective endothelial cells explain tumor vessel leakiness. Am. J. Pathol. 156(4), 1363–1380 (2000)CrossRefGoogle Scholar
  14. 14.
    Maeda, H.: The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv. Enzym Regul. 41, 189–207 (2001)CrossRefGoogle Scholar
  15. 15.
    Torchilin, V.P.: Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discov. 4(2), 145–160 (2005)CrossRefGoogle Scholar
  16. 16.
    Hrkach, J.S., Peracchia, M.T., Domb, A., Lotan, N., Langer, R.: Nanotechnology for biomaterials engineering: structural characterization of amphiphilic polymeric nanoparticles by 1H NMR spectroscopy. Biomaterials 18(1), 27–30 (1997)CrossRefGoogle Scholar
  17. 17.
    Serda, R.E., Mack, A., van de Ven, A.L., Ferrati, S., Dunner Jr., K., Godin, B., Chiappini, C., Landry, M., Brousseau, L., Liu, X., Bean, A.J., Ferrari, M.: Logic-embedded vectors for intracellular partitioning, endosomal escape, and exocytosis of nanoparticles. Small 6, 2691–2700 (2010)CrossRefGoogle Scholar
  18. 18.
    Tanaka, T., Mangala, L.S., Vivas-Mejia, P.E., Nieves-Alicea, R., Mann, A.P., Mora, E., Han, H.D., Shahzad, M.M., Liu, X., Bhavane, R., Gu, J., Fakhoury, J.R., Chiappini, C., Lu, C., Matsuo, K., et al.: Sustained small interfering RNA delivery by mesoporous silicon particles. Cancer Res. 70(9), 3687–3696 (2010)CrossRefGoogle Scholar
  19. 19.
    Serda, R.E., Ferrati, S., Godin, B., Tasciotti, E., Liu, X., Ferrari, M.: Mitotic partitioning of silicon microparticles. Nanoscale 2, 173–288 (2009)Google Scholar
  20. 20.
    Ferrati, S., Shamsudeen, S., Summers, H.D., Rees, P., Abbey, J.V., Schmulen, J., Liu, X., Wong, S.T., Bean, A. J., Ferrari, M., Serda, R.E. Small 8(20), 3151–60 (2012)CrossRefGoogle Scholar
  21. 21.
    Rustom, A., Saffrich, R., Markovic, I., Walther, P., Gerdes, H.H. Science, 303(5660), 1007–10 (2004)CrossRefGoogle Scholar
  22. 22.
    Onfelt, B., Nedvetzki, S., Benninger, R.K., Purbhoo, M. A., Sowinski, S., Hume, A. N., Seabra, M. C., Neil, M. A., French, P. M., Davis, D. M. Journal of immunology 177(12), 8476–83 (2006)CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2015

Authors and Affiliations

  1. 1.Michael E. DeBakey Department of SurgeryBaylor College of MedicineHoustonUSA
  2. 2.Department of NanoMedicineHouston Methodist Research InstituteHoustonUSA